DB
RXST icon

Dmitry Balyasny’s RxSight RXST Stock Holding History

Dmitry Balyasny’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$464K Buy
96,290
+51,497
+115% +$311K ﹤0.01% 2549
2026
Q1 		$276K Sell
44,793
-37,043
-45% -$308K ﹤0.01% 2593
2025
Q4 		$853K Sell
81,836
-252,341
-76% -$2.53M ﹤0.01% 2264
2025
Q3 		$3M Buy
+334,177
New +$2.93M ﹤0.01% 1615
2025
Q2 		– Sell
-160,627
Closed -$4.06M – 3277
2025
Q1 		$4.06M Buy
160,627
+136,649
+570% +$4.06M 0.01% 1355
2024
Q4 		$824K Buy
+23,978
New +$1.08M ﹤0.01% 2011

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Dmitry Balyasny's RXST Position: Q2 2026 in Review

Dmitry Balyasny increased its RxSight (RXST) stake by 115% in Q2 2026, buying an estimated $311K and bringing the position to 96,290 shares worth $464K. The position accounts for ﹤0.01% of the portfolio, ranked #2549.

Dmitry Balyasny first reported a position in RXST in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.06M in Q1 2025. 150 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Dmitry Balyasny held 96,290 shares of RxSight worth $464K as of Q2 2026.
  • Dmitry Balyasny bought 51,497 RxSight shares in Q2 2026, an estimated $311K.
  • RxSight made up ﹤0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #2549 holding.
  • Dmitry Balyasny first reported a position in RxSight in Q4 2024 and has held it in 6 quarters since.
  • Dmitry Balyasny's RxSight position peaked at $4.06M in Q1 2025.
  • 150 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.